Skye Bioscience Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.50

-0.04 (-7.30%)

As of Aug 15, 2:29 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +3,070.5% upside

Low Target $11.92

Average Target $15.90

High Target $19.90

Current Price $0.50

Current
$0.50

Target
$15.90

$11.92 $15.90 avg $19.90

Scenario Analysis

Bear Case

$11.92

2,276.9%

Low target

Base Case

$15.90

+3,070.5%

Avg target

Bull Case

$19.90

+3,868.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$4.99

-89.9% from high

52-Week Low

$0.28

+81.7% from low

Target vs 52W High

$15.90

+218.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%